Response to COVID-19 Vaccines in People with Chronic Conditions


Trial Objective

Response to COVID-19 Vaccines in People with Chronic ConditionsResearchers at National Jewish Health are working to understand the antibody response to COVID-19 vaccines in people with chronic diseases. Researchers are focused on the short-term and long-term antibody response by people with chronic respiratory diseases, as well as other chronic diseases.


Active Clinical Trials Closed to Recruitment

Who Can Participate

Individuals 18 and older who have received or will be receiving the COVID-19 vaccine.

Age: 18+    Gender: Any Gender

Estimated Time Commitment

Up to 10 visits over the course of about 2 years

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Madeline Caruso

Juno Pak

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Investigator Funded

Principal Investigators